메뉴 건너뛰기




Volumn 115, Issue 4, 2010, Pages 845-853

Administration of thiazolidinediones for neuroprotection in ischemic stroke: A pre-clinical systematic review

Author keywords

Ischemic stroke; Meta analysis; Pioglitazone; Rosiglitazone; Systematic review; Thiazolidinedione

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; PIOGLITAZONE; ROSIGLITAZONE;

EID: 77958610176     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06999.x     Document Type: Review
Times cited : (34)

References (44)
  • 1
    • 33750054375 scopus 로고    scopus 로고
    • Rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, reduces infarction volume and neurological deficits in an embolic model of stroke
    • Allahtavakoli M., Shabanzadeh A. P., Sadr S. S., Parviz M. and Djahanguiri B. (2006) Rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, reduces infarction volume and neurological deficits in an embolic model of stroke. Clin. Exp. Pharmacol. Physiol. 33, 1052-1058.
    • (2006) Clin. Exp. Pharmacol. Physiol. , vol.33 , pp. 1052-1058
    • Allahtavakoli, M.1    Shabanzadeh, A.P.2    Sadr, S.S.3    Parviz, M.4    Djahanguiri, B.5
  • 2
    • 34848892510 scopus 로고    scopus 로고
    • Combination therapy of rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats
    • Allahtavakoli M., Shabanzadeh A., Roohbakhsh A. and Pourshanazari A. (2007) Combination therapy of rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats. Basic Clin. Pharmacol. Toxicol. 101, 309-314.
    • (2007) Basic Clin. Pharmacol. Toxicol. , vol.101 , pp. 309-314
    • Allahtavakoli, M.1    Shabanzadeh, A.2    Roohbakhsh, A.3    Pourshanazari, A.4
  • 3
    • 67349225826 scopus 로고    scopus 로고
    • Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat
    • Allahtavakoli M., Moloudi R., Arababadi M. K., Shamsizadeh A. and Javanmardi K. (2009) Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat. Brain Res. 1271, 121-127.
    • (2009) Brain Res. , vol.1271 , pp. 121-127
    • Allahtavakoli, M.1    Moloudi, R.2    Arababadi, M.K.3    Shamsizadeh, A.4    Javanmardi, K.5
  • 4
    • 67449103220 scopus 로고    scopus 로고
    • Redefining the role of thiazolidinediones in the management of type 2 diabetes
    • Barnett A. H. (2009) Redefining the role of thiazolidinediones in the management of type 2 diabetes. Vasc. Health Risk Manag. 5, 141-51.
    • (2009) Vasc. Health Risk Manag. , vol.5 , pp. 141-51
    • Barnett, A.H.1
  • 5
    • 33745424209 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor-gamma-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia
    • Chu K., Lee S. T., Koo J. S. et al. (2006) Peroxisome proliferator-activated receptor-gamma-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia. Brain Res. 1093, 208-218.
    • (2006) Brain Res. , vol.1093 , pp. 208-218
    • Chu, K.1    Lee, S.T.2    Koo, J.S.3
  • 6
    • 33845468713 scopus 로고    scopus 로고
    • Insulin resistance syndrome and Alzheimer disease: pathophysiologic mechanisms and therapeutic implications
    • Craft S. (2006) Insulin resistance syndrome and Alzheimer disease: pathophysiologic mechanisms and therapeutic implications. Alzheimer Dis. Assoc. Disord. 20, 298-301.
    • (2006) Alzheimer Dis. Assoc. Disord. , vol.20 , pp. 298-301
    • Craft, S.1
  • 9
    • 26244453309 scopus 로고    scopus 로고
    • Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomized controlled trial
    • PROactive investigators.
    • Dormandy J. A., Charbonnel B. and Eckland D. J. et al. and PROactive investigators. (2005) Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomized controlled trial. Lancet. 366(9493), 1279-89.
    • (2005) Lancet , vol.366 , Issue.9493 , pp. 1279-89
    • Dormandy, J.A.1    Charbonnel, B.2    Eckland, D.J.3
  • 10
    • 48649107300 scopus 로고    scopus 로고
    • Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial
    • DREAM Trial Investigators,
    • DREAM Trial Investigators, Dagenais G. R., Gerstein H. C. Holman R. et al. (2008) Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial. Diabetes Care 31, 1007-14.
    • (2008) Diabetes Care , vol.31 , pp. 1007-14
    • Dagenais, G.R.1    Gerstein, H.C.2    Holman, R.3
  • 11
    • 79951943069 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) activation confers functional neuroprotection in global ischemia
    • Epub ahead of print. PMID: 20524105].
    • Fatehi-Hassanabad Z. and Tasker R. A. (2010) Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) activation confers functional neuroprotection in global ischemia. Neurotox. Res. [Epub ahead of print. PMID: 20524105].
    • (2010) Neurotox. Res.
    • Fatehi-Hassanabad, Z.1    Tasker, R.A.2
  • 13
    • 38849190685 scopus 로고    scopus 로고
    • Progesterone for the treatment of experimental brain injury; a systematic review
    • Gibson C. L., Gray L. J., Bath P. M. W. and Murphy S. P. (2008) Progesterone for the treatment of experimental brain injury; a systematic review. Brain. 131, 318-328.
    • (2008) Brain. , vol.131 , pp. 318-328
    • Gibson, C.L.1    Gray, L.J.2    Bath, P.M.W.3    Murphy, S.P.4
  • 14
    • 77954383974 scopus 로고    scopus 로고
    • Peroxisome-proliferator-activated receptors gamma and peroxisome-proliferator-activated receptors beta/delta and the regulation of interleukin 1 receptor antagonist expression by pioglitazone in ischaemic brain
    • Glatz T., Stock I., Nguyen-Ngoc M., Gohlke P., Herdegen T., Culman J. and Zhao Y. (2010) Peroxisome-proliferator-activated receptors gamma and peroxisome-proliferator-activated receptors beta/delta and the regulation of interleukin 1 receptor antagonist expression by pioglitazone in ischaemic brain. J. Hypertens. 28, 1488-1497.
    • (2010) J. Hypertens. , vol.28 , pp. 1488-1497
    • Glatz, T.1    Stock, I.2    Nguyen-Ngoc, M.3    Gohlke, P.4    Herdegen, T.5    Culman, J.6    Zhao, Y.7
  • 15
    • 77954988618 scopus 로고    scopus 로고
    • Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone
    • Graham D. J., Ouellet-Hellstrom R., MaCurdy T. E., Ali F., Sholley C., Worrall C. and Kelman J. A. (2010) Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone. JAMA 304, 411-418.
    • (2010) JAMA , vol.304 , pp. 411-418
    • Graham, D.J.1    Ouellet-Hellstrom, R.2    MaCurdy, T.E.3    Ali, F.4    Sholley, C.5    Worrall, C.6    Kelman, J.A.7
  • 16
    • 58149265311 scopus 로고    scopus 로고
    • Pioglitazone improved cognition in a pilot study on patients with Alzheimer's disease and mild cognitive impairment with diabetes mellitus
    • Hanyu H., Sato T., Kiuchi A., Sakurai H. and Iwamoto T. (2009) Pioglitazone improved cognition in a pilot study on patients with Alzheimer's disease and mild cognitive impairment with diabetes mellitus. J. Am. Geriatr. Soc. 57, 177-179.
    • (2009) J. Am. Geriatr. Soc. , vol.57 , pp. 177-179
    • Hanyu, H.1    Sato, T.2    Kiuchi, A.3    Sakurai, H.4    Iwamoto, T.5
  • 18
    • 62049083791 scopus 로고    scopus 로고
    • Acute neuroprotection by pioglitazone after mild brain ischemia without effect on long-term outcome
    • Ji S., Kronenberg G., Balkaya M., Farber K., Gertz K., Kettenmann H. and Endres M. (2009) Acute neuroprotection by pioglitazone after mild brain ischemia without effect on long-term outcome. Exp. Neurol. 216, 321-328.
    • (2009) Exp. Neurol. , vol.216 , pp. 321-328
    • Ji, S.1    Kronenberg, G.2    Balkaya, M.3    Farber, K.4    Gertz, K.5    Kettenmann, H.6    Endres, M.7
  • 19
    • 77949480066 scopus 로고    scopus 로고
    • Exercise training ameliorates the effects of rosiglitazone on traditional and novel cardiovascular risk factors in patients with type 2 diabetes mellitus
    • Kadoglou N. P., Iliadis F., Sailer N. et al. (2010) Exercise training ameliorates the effects of rosiglitazone on traditional and novel cardiovascular risk factors in patients with type 2 diabetes mellitus. Metabolism 59, 599-607.
    • (2010) Metabolism , vol.59 , pp. 599-607
    • Kadoglou, N.P.1    Iliadis, F.2    Sailer, N.3
  • 20
    • 66149192431 scopus 로고    scopus 로고
    • Antidepressant response associated with pioglitazone: support for an overlapping pathophysiology between major depression and metabolic syndrome
    • Kemp D. E., Ismail-Beigi F. and Calabrese J. R. (2009) Antidepressant response associated with pioglitazone: support for an overlapping pathophysiology between major depression and metabolic syndrome. Am. J. Psychiatry 166, 619.
    • (2009) Am. J. Psychiatry , vol.166 , pp. 619
    • Kemp, D.E.1    Ismail-Beigi, F.2    Calabrese, J.R.3
  • 21
    • 59649090954 scopus 로고    scopus 로고
    • PPARgamma agonist pioglitazone reduces matrix metalloproteinase-9 activity and neuronal damage after focal cerebral ischemia
    • Lee S. R., Kim H. Y., Hong J. S., Baek W. K. and Park J. W. (2009) PPARgamma agonist pioglitazone reduces matrix metalloproteinase-9 activity and neuronal damage after focal cerebral ischemia. Biochem. Biophys. Res. Commun. 380, 17-21.
    • (2009) Biochem. Biophys. Res. Commun. , vol.380 , pp. 17-21
    • Lee, S.R.1    Kim, H.Y.2    Hong, J.S.3    Baek, W.K.4    Park, J.W.5
  • 23
    • 20444398490 scopus 로고    scopus 로고
    • Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivative through peroximsome proliferator-activated receptor gamma activation
    • Luna-Medina R., Cortes-Canteli M., Alonso M., Santos A., Martinez Al. and Perez-Castillo A. (2005) Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivative through peroximsome proliferator-activated receptor gamma activation. J. Biol. Chem. 280, 21453-62.
    • (2005) J. Biol. Chem. , vol.280 , pp. 21453-62
    • Luna-Medina, R.1    Cortes-Canteli, M.2    Alonso, M.3    Santos, A.4    Martinez, A.5    Perez-Castillo, A.6
  • 24
    • 33645323521 scopus 로고    scopus 로고
    • Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone
    • Luo Y., Yin W., Signore A. P., Zhang F., Hong Z., Wang S., Graham S. H. and Chen J. (2006) Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. J. Neurochem. 97, 435-448.
    • (2006) J. Neurochem. , vol.97 , pp. 435-448
    • Luo, Y.1    Yin, W.2    Signore, A.P.3    Zhang, F.4    Hong, Z.5    Wang, S.6    Graham, S.H.7    Chen, J.8
  • 26
    • 33751533892 scopus 로고    scopus 로고
    • International Union of Pharmacology LXI. Peroxisome proliferator-activated receptors
    • Michalik L., Auwerx J., Berger J. P. et al. (2006) International Union of Pharmacology LXI. Peroxisome proliferator-activated receptors. Pharmacol. Rev. 58, 726-741.
    • (2006) Pharmacol. Rev. , vol.58 , pp. 726-741
    • Michalik, L.1    Auwerx, J.2    Berger, J.P.3
  • 28
    • 34250212715 scopus 로고    scopus 로고
    • Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
    • Nissen S. E. and Wolski K. (2007) Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N. Engl. J. Med. 356, 2457-2471.
    • (2007) N. Engl. J. Med. , vol.356 , pp. 2457-2471
    • Nissen, S.E.1    Wolski, K.2
  • 29
    • 31444445868 scopus 로고    scopus 로고
    • Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms
    • Pereira M. P., Hurtado O., Cardenas A. et al. (2006) Rosiglitazone and 15-deoxy-Delta12, 14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms. J. Cereb. Blood Flow Metab. 26, 218-229.
    • (2006) J. Cereb. Blood Flow Metab. , vol.26 , pp. 218-229
    • Pereira, M.P.1    Hurtado, O.2    Cardenas, A.3
  • 30
    • 77749296286 scopus 로고    scopus 로고
    • Rosiglitazone add-on in treatment of depressed patients with insulin resistance: a pilot study
    • Rasgon N. L., Kenna H. A., Williams K. E., Powers B., Wroolie T. and Schatzberg A. F. (2010) Rosiglitazone add-on in treatment of depressed patients with insulin resistance: a pilot study. Sci. World J. 10, 321-8.
    • (2010) Sci. World J. , vol.10 , pp. 321-8
    • Rasgon, N.L.1    Kenna, H.A.2    Williams, K.E.3    Powers, B.4    Wroolie, T.5    Schatzberg, A.F.6
  • 31
    • 43049094346 scopus 로고    scopus 로고
    • Comparison between single and combined treatment with candesartan and pioglitazone following transient focal ischemia in rat brain
    • Schmerbach K., Schefe J. H., Krikov M., Muller S., Villringer A., Kintscher U., Unger T. and Thoene-Reineke C. (2008) Comparison between single and combined treatment with candesartan and pioglitazone following transient focal ischemia in rat brain. Brain Res. 1208, 225-233.
    • (2008) Brain Res. , vol.1208 , pp. 225-233
    • Schmerbach, K.1    Schefe, J.H.2    Krikov, M.3    Muller, S.4    Villringer, A.5    Kintscher, U.6    Unger, T.7    Thoene-Reineke, C.8
  • 33
    • 12844281747 scopus 로고    scopus 로고
    • A peroxisome proliferator-activated receptor-gamma agonist reduces infarct size in transient but not in permanent ischemia
    • Shimazu T., Inoue I., Araki N., Asano Y., Sawada M., Furuya D., Nagoya H. and Greenberg J. H. (2005) A peroxisome proliferator-activated receptor-gamma agonist reduces infarct size in transient but not in permanent ischemia. Stroke 36, 353-359.
    • (2005) Stroke , vol.36 , pp. 353-359
    • Shimazu, T.1    Inoue, I.2    Araki, N.3    Asano, Y.4    Sawada, M.5    Furuya, D.6    Nagoya, H.7    Greenberg, J.H.8
  • 34
    • 77649270079 scopus 로고    scopus 로고
    • Effects of pioglitazone on diffusion tensor imaging indices in multiple sclerosis patients
    • Shukla D. K., Kaiser C. C., Stebbins G. T. and Feinstein D. L. (2010) Effects of pioglitazone on diffusion tensor imaging indices in multiple sclerosis patients. Neurosci. Lett. 472, 153-156.
    • (2010) Neurosci. Lett. , vol.472 , pp. 153-156
    • Shukla, D.K.1    Kaiser, C.C.2    Stebbins, G.T.3    Feinstein, D.L.4
  • 35
    • 64849099379 scopus 로고    scopus 로고
    • Synthesis of lipoxin A4 by 5-lipoxygenase mediates PPARgamma-dependent, neuroprotective effects of rosiglitazone in experimental stroke
    • Sobrado M., Pereira M. P., Ballesteros I. et al. (2009) Synthesis of lipoxin A4 by 5-lipoxygenase mediates PPARgamma-dependent, neuroprotective effects of rosiglitazone in experimental stroke. J. Neurosci. 29, 3875-3884.
    • (2009) J. Neurosci. , vol.29 , pp. 3875-3884
    • Sobrado, M.1    Pereira, M.P.2    Ballesteros, I.3
  • 36
    • 10044289268 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia
    • Sundararajan S., Gamboa J. L., Victor N. A., Wanderi E. W., Lust W. D. and Landreth G. E. (2005) Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia. Neuroscience 130, 685-696.
    • (2005) Neuroscience , vol.130 , pp. 685-696
    • Sundararajan, S.1    Gamboa, J.L.2    Victor, N.A.3    Wanderi, E.W.4    Lust, W.D.5    Landreth, G.E.6
  • 37
    • 33947204503 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents
    • Tureyen K., Kapadia R., Bowen K. K., Satriotomo I., Liang J., Feinstein D. L. and Vemuganti R. (2007) Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents. J. Neurochem. 101, 41-56.
    • (2007) J. Neurochem. , vol.101 , pp. 41-56
    • Tureyen, K.1    Kapadia, R.2    Bowen, K.K.3    Satriotomo, I.4    Liang, J.5    Feinstein, D.L.6    Vemuganti, R.7
  • 39
    • 70349671387 scopus 로고    scopus 로고
    • Rosiglitazone alone or in combination with tissue plasminogen activator improves ischemic brain injury in an embolic model in rats
    • Wang C. X., Ding X., Noor R., Pegg C., He C. and Shuaib A. (2009) Rosiglitazone alone or in combination with tissue plasminogen activator improves ischemic brain injury in an embolic model in rats. J. Cereb. Blood Flow Metab. 29, 1683-1694.
    • (2009) J. Cereb. Blood Flow Metab. , vol.29 , pp. 1683-1694
    • Wang, C.X.1    Ding, X.2    Noor, R.3    Pegg, C.4    He, C.5    Shuaib, A.6
  • 40
    • 62649096776 scopus 로고    scopus 로고
    • Ligand-activated peroxisome proliferator-activated receptor-gamma protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3 epsilon upregulation
    • Wu J. S., Cheung W. M., Tsai Y. S. et al. (2009) Ligand-activated peroxisome proliferator-activated receptor-gamma protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3 epsilon upregulation. Circulation 119, 1124-1134.
    • (2009) Circulation , vol.119 , pp. 1124-1134
    • Wu, J.S.1    Cheung, W.M.2    Tsai, Y.S.3
  • 41
    • 56049113451 scopus 로고    scopus 로고
    • PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms
    • Yi J. H., Park S. W., Brooks N., Lang B. T. and Vemuganti R. (2008) PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms. Brain Res. 1244, 164-172.
    • (2008) Brain Res. , vol.1244 , pp. 164-172
    • Yi, J.H.1    Park, S.W.2    Brooks, N.3    Lang, B.T.4    Vemuganti, R.5
  • 42
    • 19244365650 scopus 로고    scopus 로고
    • Thiazolidinediones
    • Yki-Jarvinen H. (2004) Thiazolidinediones N. Engl. J. Med. 351, 1106-1118.
    • (2004) N. Engl. J. Med. , vol.351 , pp. 1106-1118
    • Yki-Jarvinen, H.1
  • 43
    • 23044475502 scopus 로고    scopus 로고
    • The intracerebral application of the PPARgamma-ligand pioglitazone confers neuroprotection against focal ischaemia in the rat brain
    • Zhao Y., Patzer A., Gohlke P., Herdegen T. and Culman J. (2005) The intracerebral application of the PPARgamma-ligand pioglitazone confers neuroprotection against focal ischaemia in the rat brain. Eur. J. Neurosci. 22, 278-282.
    • (2005) Eur. J. Neurosci. , vol.22 , pp. 278-282
    • Zhao, Y.1    Patzer, A.2    Gohlke, P.3    Herdegen, T.4    Culman, J.5
  • 44
    • 33745983234 scopus 로고    scopus 로고
    • Activation of cerebral peroxisome proliferator-activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats
    • Zhao Y., Patzer A., Herdegen T., Gohlke P. and Culman J. (2006) Activation of cerebral peroxisome proliferator-activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats. FASEB J. 20, 1162-1175.
    • (2006) FASEB J. , vol.20 , pp. 1162-1175
    • Zhao, Y.1    Patzer, A.2    Herdegen, T.3    Gohlke, P.4    Culman, J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.